全文获取类型
收费全文 | 301篇 |
免费 | 19篇 |
国内免费 | 22篇 |
专业分类
基础医学 | 46篇 |
临床医学 | 27篇 |
内科学 | 22篇 |
皮肤病学 | 2篇 |
神经病学 | 48篇 |
特种医学 | 10篇 |
外国民族医学 | 1篇 |
外科学 | 21篇 |
综合类 | 68篇 |
预防医学 | 28篇 |
药学 | 34篇 |
中国医学 | 27篇 |
肿瘤学 | 8篇 |
出版年
2024年 | 2篇 |
2023年 | 1篇 |
2022年 | 18篇 |
2021年 | 15篇 |
2020年 | 12篇 |
2019年 | 7篇 |
2018年 | 12篇 |
2017年 | 2篇 |
2016年 | 16篇 |
2015年 | 14篇 |
2014年 | 14篇 |
2013年 | 18篇 |
2012年 | 26篇 |
2011年 | 20篇 |
2010年 | 24篇 |
2009年 | 12篇 |
2008年 | 15篇 |
2007年 | 19篇 |
2006年 | 8篇 |
2005年 | 6篇 |
2004年 | 7篇 |
2003年 | 7篇 |
2002年 | 13篇 |
2001年 | 16篇 |
2000年 | 9篇 |
1999年 | 12篇 |
1998年 | 3篇 |
1997年 | 5篇 |
1996年 | 3篇 |
1995年 | 2篇 |
1993年 | 1篇 |
1991年 | 1篇 |
1988年 | 2篇 |
排序方式: 共有342条查询结果,搜索用时 15 毫秒
1.
目的快速鉴定血培养中的金黄色葡萄球菌和凝固酶阴性葡萄球菌(CoNS),结合临床快速判定是否为污染菌。方法采用荧光原位杂交法鉴定血培养中的金黄色葡萄球菌和CoNS,杂交结果若为CoNS,根据临床资料进行判断,并与文献推荐的污染判断法进行结果比较。结果探针的特异性经由标准菌株和临床分离菌株证实。金黄色葡萄球菌探针的特异性和敏感性均为100%,GoNS探针的特异性和敏感性分别为100%和95.5%。179株CoNS中117株判断为污染菌,污染率为68%,与文献推荐的污染判断方法一致。结论荧光原位杂交法适用于血培养中的金黄色葡萄球菌和CoNS的快速鉴定,以排除CoNS污染。 相似文献
2.
南京口岸1987—1993年艾滋病监测报告 总被引:1,自引:1,他引:0
本文报道了南京卫生检疫局1987~1993连续7年对南京口岸重点人群进行艾滋病监测的情况.7年来南京局共监测各类标本43085份,在外籍留学生中检出HIV感染者2例,另外还检出4份进口人血丙种球旦白HIV抗体阳性.该局对检出的2侧HIV感染者及4份阳性进口人血丙种球旦白进行了游行病学调查和处理.并对艾滋病监测管理的有关问题进行了探讨. 相似文献
3.
胆总管的矢状断层解剖研究 总被引:1,自引:0,他引:1
在30套成人腹部连续矢状断层标本上,胆总管与下腔静脉主要出现于R2-R3断层;胆总管胰腺段与胰头的关系有部分包埋,完全包埋及胰腺后型;十二指肠大乳头集中出现于R3断层;胆总管的行程有4种形式。文内还探讨了矢状断层里胆总管各段的毗邻及识别标志。 相似文献
4.
为了保证民法的公平原则,避免医疗纠纷赔偿案件审理中忽视患者本身病情所致的不良后果的情况,对损伤与疾病对患者预后的影响进行了研究.介绍了伤病比的来源,论述了伤病比在医疗纠纷处理中的适用 范围,伤病比的级别与医院承担的赔偿额度.指出应增强伤病比意识,促进医与法的完美结合. 相似文献
5.
6.
7.
透析前注射单剂量低分子量肝素对透析器复用效率的评价 总被引:5,自引:0,他引:5
目的 评价血透前注射单剂量低分子量肝素(LMWH)与持续输注普通肝素(SH)对复用透析器效率的影响。方法 对30例慢性透析患者进行随机交叉对照研究,观察第1、4次透析的透析器纤维包裹容量(FBV)、透析前血球压积(HCT)及透析2h尿素氮、肌酐清除率;另外,利用生色底物法测定透析0h,2h,4h血浆肝素抗-Fxa水平。结果 同SH组比,LMWH组透析器复用次数增加(P<0.05),第4次复用透析器FBV及透析2h尿素氮、肌酐清除率无下降(P>0.05),SH组则下降(P<0.05),透析2h两组血浆肝素活性-Fxa水平差异无显著性(P>0.05),透析4hLWMH组高于SH组(P<0.05)。结论 透析前单剂量注射LMWH能有效地保护复用透析器清除率,值得临床上进一步推广。 相似文献
8.
通过对我国五所大学的个案研究,总结和分析了当前我国大学信息化体制的组织结构及其特点,并从“IT部门、院系、行政部处”三者间信息化权责关系的协调处理—这一信息化体制的功能目的的视角剖析了其运行机制及存在的问题,提出我国大学信息化发展的现实需求以及遭遇的体制困境. 相似文献
9.
Wenbin Zhong Zhenyu Shi Surendra H. Mahadevegowda Bo Liu Kaixi Zhang Chong Hui Koh Lin Ruan Yahua Chen Merve S. Zeden Carmen J. E. Pee Kalisvar Marimuthu Partha Pratim De Oon Tek Ng Yabin Zhu Yonggui Robin Chi Paula T. Hammond Liang Yang Yunn-Hwen Gan Kevin Pethe E. Peter Greenberg Angelika Gründling Mary B. Chan-Park 《Proceedings of the National Academy of Sciences of the United States of America》2020,117(49):31376
For a myriad of different reasons most antimicrobial peptides (AMPs) have failed to reach clinical application. Different AMPs have different shortcomings including but not limited to toxicity issues, potency, limited spectrum of activity, or reduced activity in situ. We synthesized several cationic peptide mimics, main-chain cationic polyimidazoliums (PIMs), and discovered that, although select PIMs show little acute mammalian cell toxicity, they are potent broad-spectrum antibiotics with activity against even pan-antibiotic-resistant gram-positive and gram-negative bacteria, and mycobacteria. We selected PIM1, a particularly potent PIM, for mechanistic studies. Our experiments indicate PIM1 binds bacterial cell membranes by hydrophobic and electrostatic interactions, enters cells, and ultimately kills bacteria. Unlike cationic AMPs, such as colistin (CST), PIM1 does not permeabilize cell membranes. We show that a membrane electric potential is required for PIM1 activity. In laboratory evolution experiments with the gram-positive Staphylococcus aureus we obtained PIM1-resistant isolates most of which had menaquinone mutations, and we found that a site-directed menaquinone mutation also conferred PIM1 resistance. In similar experiments with the gram-negative pathogen Pseudomonas aeruginosa, PIM1-resistant mutants did not emerge. Although PIM1 was efficacious as a topical agent, intraperitoneal administration of PIM1 in mice showed some toxicity. We synthesized a PIM1 derivative, PIM1D, which is less hydrophobic than PIM1. PIM1D did not show evidence of toxicity but retained antibacterial activity and showed efficacy in murine sepsis infections. Our evidence indicates the PIMs have potential as candidates for development of new drugs for treatment of pan-resistant bacterial infections.AMPs and AMP mimics have attracted considerable attention as candidates for therapeutic development (1). The basic design elements include a region of charged residues, generally cationic residues, enabling interaction with bacterial cell surfaces, combined with a hydrophobic nature in AMPs (2). Unfortunately, AMPs and related polymers, in general, have one or more issues that limit their use as broad-spectrum antibiotics. Some are quite toxic to human cells, the potency of some is not adequate for human administration, others are sensitive to salt at levels present in human fluids, and some are too difficult and expensive to synthesize (3, 4). One broad-spectrum antimicrobial peptide, CST has seen increased recent use as a last resort antibiotic. CST is believed to kill bacteria by virtue of its ability to disrupt membrane integrity (5). This antibiotic requires intravenous administration and is nephrotoxic (6). The emergence of CST-resistant pathogens has also become a significant problem (7). We are unaware of any new broad-spectrum AMPs that have advanced to clinical trials.Imidazolium (IM) salts are antimicrobials (8), and there is an emerging literature on antimicrobial activity of side-chain and main-chain polyimidazolium (PIM) salts with chemical structures that are in some ways similar to those we describe. Although PIMs are potent antimicrobials, there are biocompatibility problems hindering their development, and some have somewhat limited activity spectra. As with other AMPs, there have been toxicity issues, potency issues, and delivery issues as many have large molecular masses, and there is little known about mammalian cell toxicity or mechanism of action (9–12).Here we show that members of a series of PIMs we designed and synthesized are potent broad-spectrum antibacterial compounds. We selected two for further analysis and showed they retain activity even against pan-antibiotic-resistant bacteria. Unlike CST and many other AMPs, which disrupt bacterial membranes, our model PIM is bactericidal without disrupting bacterial membranes. Our experiments provide insights about mechanism of action, the potential for the emergence of PIM resistance, and indicate PIMs are effective against a model gram-negative and a model gram-positive pathogen in murine infection models. 相似文献
10.